Many people who remain persistently seronegative despite frequent HIV exposure have HIV-specific immune responses. The study of these may provide information about mechanisms of natural protective immunity to HIV-1. We describe the specificity of cytotoxic T lymphocyte responses to HIV in seronegative prostitutes in Nairobi who are apparently resistant to HIV infection. These women have had frequent exposure to a range of African HIV-1 variants, primarily clades A, C, and D, for up to 12 yr without becoming infected. Nearly half of them have CTL directed towards epitopes previously defined for B clade virus, which are largely conserved in the A and D clade sequences. Stronger responses are frequently elicited using the A or D clade version of an epitope to stimulate CTL, suggesting that they were originally primed by exposure to these virus strains. CTL responses have been defined to novel epitopes presented by HLA class I molecules associated with resistance to infection in the cohort, HLA-A*6802 and HLA-B18. Estimates using a modified interferon-gamma Elispot assay indicate a circulating frequency of CTL to individual epitopes of between 1:3,200 and 1:50,000. Thus, HIV-specific immune responses-particularly cross-clade CTL activity- may be responsible for protection against persistent HIV infection in these African women.
S L Rowland-Jones, T Dong, K R Fowke, J Kimani, P Krausa, H Newell, T Blanchard, K Ariyoshi, J Oyugi, E Ngugi, J Bwayo, K S MacDonald, A J McMichael, F A Plummer
Title and authors | Publication | Year |
---|---|---|
Dyspareunia, signs of epithelial disruption, sexual abstinence, and HIV status in female sex workers in Nairobi: a cross-sectional study.
Fischer B, Jaoko W, Kirui E, Muture B, Madegwa I, Kageni L |
BMC Infectious Diseases | 2023 |
HIV-1 protective epitope-specific CD8+ T cells in HIV-1-exposed seronegative individuals
Chikata T, Gatanaga H, Nguyen HT, Mizushima D, Zhang Y, Kuse N, Oka S, Takiguchi M |
iScience | 2023 |
High level of plasma TILRR protein is associated with faster HIV seroconversion
M Kashem, J Lischynski, B Stojak, L Li, X Yuan, B Liang, J Kimani, F Plummer, M Luo |
EBioMedicine | 2022 |
Natural Immunity against HIV-1: Progression of Understanding after Association Studies
Luo M |
Viruses | 2022 |
Immunological control of HIV-1 disease progression by rare protective HLA allele
Yu Zhang, Takayuki Chikata, Nozomi Kuse, Hayato Murakoshi, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi |
Journal of virology | 2022 |
CD8+ T-Cell Mediated Control of HIV-1 in a Unique Cohort With Low Viral Loads
AD Jones, S Khakhina, T Jaison, E Santos, S Smith, ZA Klase |
Frontiers in microbiology | 2021 |
The Potential Role of FREM1 and Its Isoform TILRR in HIV-1 Acquisition through Mediating Inflammation
MA Kashem, H Li, LR Liu, B Liang, RW Omange, FA Plummer, M Luo |
International journal of molecular sciences | 2021 |
Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.
Cromarty R, Archary D |
AIDS Research and Treatment | 2020 |
Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
N Saubi, A Kilpeläinen, Y Eto, CW Chen, À Olvera, T Hanke, C Brander, J Joseph-Munné |
Human vaccines | 2020 |
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
M Surenaud, M Montes, CS Arlehamn, A Sette, J Banchereau, K Palucka, JD Lelièvre, C Lacabaratz, Y Lévy, G Silvestri |
PLoS pathogens | 2019 |
Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
A Kilpeläinen, N Saubi, N Guitart, N Moyo, EG Wee, K Ravi, T Hanke, J Joseph |
Frontiers in immunology | 2019 |
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
E Broset, N Saubi, N Guitart, N Aguilo, S Uranga, A Kilpeläinen, Y Eto, T Hanke, J Gonzalo-Asensio, C Martín, J Joseph-Munné |
Molecular Therapy — Methods & Clinical Development | 2019 |
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
A Kilpeläinen, N Saubi, N Guitart, A Olvera, T Hanke, C Brander, J Joseph |
Human vaccines | 2019 |
Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned
A Kilpeläinen, M Maya-Hoyos, N Saubí, CY Soto, JJ Munne |
Expert Review of Vaccines | 2018 |
Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico
M Soto-Nava, S Avila-Ríos, H Valenzuela-Ponce, C García-Morales, JM Carlson, D Tapia-Trejo, D Garrido-Rodriguez, SN Alva-Hernández, TA García-Tellez, A Murakami-Ogasawara, SA Mallal, M John, MA Brockman, CJ Brumme, ZL Brumme, G Reyes-Teran, G Silvestri |
Journal of virology | 2017 |
Preclinical Development of BCG.HIVA 2auxo.int , Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity
A Mahant, N Saubi, Y Eto, N Guitart, JM Gatell, T Hanke, J Joseph |
Human Vaccines & Immunotherapeutics | 2017 |
Preclinical Development of BCG.HIVA 2auxo.int , Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity
A Mahant, N Saubi, Y Eto, N Guitart, JM Gatell, T Hanke, J Joseph |
Human Vaccines & Immunotherapeutics | 2017 |
Exploiting Mucosal Immunity for Antiviral Vaccines
A Iwasaki |
Annual Review of Immunology | 2016 |
Effects of the Cytotoxic T-Cells on the Dynamics of Co-Infection of HIV-1 and Mycobacterium tuberculosis
C Mufudza, SD Hove-Musekwa, ET Chiyaka |
Journal of Tuberculosis Research | 2016 |
Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes
H Murakoshi, T Akahoshi, M Koyanagi, T Chikata, T Naruto, R Maruyama, Y Tamura, N Ishizuka, H Gatanaga, S Oka, M Takiguchi |
Journal of virology | 2015 |
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial
PJ Kuebler, ML Mehrotra, JJ McConnell, SJ Holditch, BI Shaw, LF Tarosso, KS Leadabrand, JM Milush, VA York, RA Raposo, RG Cheng, EM Eriksson, V McMahan, DV Glidden, S Shiboski, RM Grant, DF Nixon, EG Kallás |
Proceedings of the National Academy of Sciences | 2015 |
HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes
SA Abdulhaqq, C Zorrilla, G Kang, X Yin, V Tamayo, KE Seaton, J Joseph, S Garced, GD Tomaras, KA Linn, AS Foulkes, L Azzoni, M VerMilyea, C Coutifaris, AV Kossenkov, L Showe, EN Kraiselburd, Q Li, LJ Montaner |
Mucosal Immunology | 2015 |
Identification of HLA-C restricted, HIV-1-specific CTL epitopes by peptide induced upregulation of HLA-C expression
A Stoll, S Bergmann, C Mummert, SM Mueller-Schmucker, BM Spriewald, EG Harrer, T Harrer |
Journal of Immunological Methods | 2015 |
Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya: Maternal HIV levels and IFN-γ responses
AY Liu, B Lohman-Payne, MH Chung, J Kiarie, J Kinuthia, J Slyker, B Richardson, D Lehman, C Farquhar, G John-Stewart |
Clinical & Experimental Immunology | 2015 |
Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage
D Archary, LJ Liebenberg, L Werner, S Tulsi, N Majola, N Naicker, S Dlamini, TJ Hope, N Samsunder, SS Karim, L Morris, JA Passmore, NJ Garrett, G Tachedjian |
PloS one | 2015 |
A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV
E Poteet, P Lewis, F Li, S Zhang, J Gu, C Chen, SO Ho, T Do, SM Chiang, G Fujii, Q Yao, S Lu |
PloS one | 2015 |
Serial Cervicovaginal Exposures With Replication-Deficient SIVsm Induce Higher Dendritic Cell (pDC) and CD4+ T-Cell Infiltrates Not Associated With Prevention but a More Severe SIVmac251 Infection of Rhesus Macaques:
SA Abdulhaqq, MI Martinez, G Kang, AS Foulkes, IV Rodriguez, SM Nichols, M Hunter, CA Sariol, LA Ruiz, BN Ross, X Yin, DW Speicher, AT Haase, PA Marx, Q Li, EN Kraiselburd, LJ Montaner |
Journal of acquired immune deficiency syndromes (1999) | 2014 |
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
KE Seaton, L Ballweber, A Lan, M Donathan, S Hughes, L Vojtech, MA Moody, HX Liao, BF Haynes, CG Galloway, BA Richardson, SA Karim, CS Dezzutti, MJ McElrath, GD Tomaras, F Hladik |
PloS one | 2014 |
Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
N Saubi, E Gea-Mallorquí, P Ferrer, C Hurtado, S Sánchez-Úbeda, Y Eto, JM Gatell, T Hanke, J Joseph |
Molecular Therapy — Methods & Clinical Development | 2014 |
Influence of HLA class I haplotypes on HIV-1 seroconversion and disease progression in Pumwani sex worker cohort
R Sampathkumar, HO Peters, L Mendoza, T Bielawny, E Ngugi, J Kimani, C Wachihi, FA Plummer, M Luo |
PloS one | 2014 |
Association between Cellular Immune Activation, Target Cell Frequency, and Risk of Human Immunodeficiency Virus Type 1 Superinfection
CA Blish, OC Dogan, W Jaoko, RS McClelland, K Mandaliya, K Odem-Davis, BA Richardson, J Overbaugh |
Journal of virology | 2014 |
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
IS Fourati, AJ Grenier, É Jolette, N Merindol, P Ovetchkine, H Soudeyns |
Journal of visualized experiments : JoVE | 2014 |
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
KE Seaton, L Ballweber, A Lan, M Donathan, S Hughes, L Vojtech, MA Moody, HX Liao, BF Haynes, CG Galloway, BA Richardson, SA Karim, CS Dezzutti, MJ McElrath, GD Tomaras, F Hladik, K Broliden |
PloS one | 2014 |
Influence of HLA Class I Haplotypes on HIV-1 Seroconversion and Disease Progression in Pumwani Sex Worker Cohort
R Sampathkumar, HO Peters, L Mendoza, T Bielawny, E Ngugi, J Kimani, C Wachihi, FA Plummer, M Luo, JD Barbour |
PloS one | 2014 |
Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity
X Pan, LC Huang, T Dong, Y Peng, V Cerundolo, S McGowan, G Ogg |
Journal of Immunological Methods | 2013 |
Ongoing Risk Behavior and the Presence of HCV-RNA Affect the Hepatitis C Virus (HCV)-Specific CD4 + T Cell Response
CH van Berg, NM Nanlohy, TJ van de Laar, M Prins, D Baarle |
Viral Immunology | 2013 |
Combinatorial HLA-peptide bead libraries for high throughput identification of CD8(+) T cell specificity
X Pan, LC Huang, T Dong, Y Peng, V Cerundolo, S McGowan, G Ogg |
Journal of Immunological Methods | 2013 |
Vaccines
RW Sutter, OM Kew, SL Cochi, RB Aylward |
Human vaccines | 2013 |
Immune Quiescence: a model of protection against HIV infection
CM Card, TB Ball, KR Fowke |
Retrovirology | 2013 |
Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patients
YS Choi, JE Lee, SJ Nam, JT Park, HS Kim, KH Choi, BS Kim, EC Shin |
PloS one | 2013 |
Two Distinct Functional Patterns of Hepatitis C Virus (HCV)-Specific T Cell Responses in Seronegative, Aviremic Patients
YS Choi, JE Lee, SJ Nam, JT Park, HS Kim, KH Choi, BS Kim, EC Shin, SA Rizza |
PloS one | 2013 |
Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides
K Watanabe, H Murakoshi, Y Tamura, M Koyanagi, T Chikata, H Gatanaga, S Oka, M Takiguchi |
Microbes and infection / Institut Pasteur | 2013 |
Benefit Sharing
D Schroeder, JC Lucas |
2013 | |
Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes
L Niu, H Cheng, S Zhang, S Tan, Y Zhang, J Qi, J Liu, GF Gao |
Molecular Immunology | 2013 |
Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones
JD Lifson, NL Haigwood |
Cold Spring Harbor Perspectives in Medicine | 2012 |
Natural Immunity to HIV: a delicate balance between strength and control
J Poudrier, V Thibodeau, M Roger |
Clinical & developmental immunology | 2012 |
A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort
M Luo, J Sainsbury, J Tuff, PA Lacap, XY Yuan, T Hirbod, J Kimani, C Wachihi, S Ramdahin, T Bielawny, J Embree, K Broliden, TB Ball, FA Plummer |
Journal of virology | 2012 |
HIV-1-Specific Enzyme-Linked Immunosorbent Spot Assay Responses in HIV-1-Exposed Uninfected Partners in Discordant Relationships Compared to Those in Low-Risk Controls
BL Guthrie, B Lohman-Payne, AY Liu, R Bosire, SV Nuvor, RY Choi, RD Mackelprang, JN Kiarie, SC Rosa, BA Richardson, GC John-Stewart, C Farquhar |
Clinical and vaccine immunology : CVI | 2012 |
HIV-1 Vaccine Trials: Evolving Concepts and Designs
MP Sanou, AS Groot, M Murphey-Corb, JA Levy, JK Yamamoto |
The open AIDS journal | 2012 |
Pre-Clinical Development of BCG.HIVACAT, an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
N Saubi, A Mbewe-Mvula, E Gea-Mallorqui, M Rosario, JM Gatell, T Hanke, J Joseph |
PloS one | 2012 |
The Immune System and Resisting HIV Infection
KR Fowke, CM Card, R Kaul |
Models of Protection Against HIV/SIV | 2012 |
HIV-1 superinfection :
L Waters, E Smit |
Current Opinion in Infectious Diseases | 2012 |
Immunization with Multiple Vaccine Modalities Induce Strong HIV-Specific Cellular and Humoral Immune Responses
D Hallengärd, SE Applequist, S Nyström, AK Maltais, M Marovich, B Moss, P Earl, K Nihlmark, B Wahren, A Bråve |
Viral Immunology | 2012 |
HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality
V Madhavi, SJ Kent, I Stratov |
Expert Review of Clinical Immunology | 2012 |
Sande's HIV/AIDS Medicine
JS Greenspan, D Greenspan |
Sande's HIV/AIDS Medicine | 2012 |
Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates
B Cameron, S Galbraith, H Li, A Lloyd |
Journal of Viral Hepatitis | 2012 |
Differences in HIV-Specific T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative Individuals ▿ †
AJ Ritchie, SL Campion, J Kopycinski, Z Moodie, ZM Wang, K Pandya, S Moore, MK Liu, S Brackenridge, K Kuldanek, K Legg, MS Cohen, EL Delwart, BF Haynes, S Fidler, AJ McMichael, N Goonetilleke |
Journal of virology | 2011 |
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
MP Girard, S Osmanov, OM Assossou, MP Kieny |
Vaccine | 2011 |
Encyclopedia of Life Sciences
B Dahlbäck |
Encyclopedia of Life Sciences | 2011 |
Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population
W Song, D He, I Brill, R Malhotra, J Mulenga, S Allen, E Hunter, J Tang, RA Kaslow |
PloS one | 2011 |
AIDS vaccines and preexposure prophylaxis: is synergy possible?
JL Excler, W Rida, F Priddy, J Gilmour, AB McDermott, A Kamali, O Anzala, G Mutua, EJ Sanders, W Koff, S Berkley, P Fast |
AIDS Research and Human Retroviruses | 2011 |
Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women:
E Delwart, F Bernardin, TH Lee, V Winkelman, C Liu, H Sheppard, A Liu, R Greenblatt, K Anastos, J DeHovitz, M Nowicki, M Cohen, ET Golub, J Barbour, S Buchbinder, MP Busch |
AIDS | 2011 |
An immunological comparison between lipidated and non-lipidated multivalent HIV-1 peptides representing Gp120 and Gag hypervariable regions
H Ghunaim, A Kumar, J Torres, F Diaz-Mitoma, A Azizi |
Vaccine | 2011 |
Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population
W Song, D He, I Brill, R Malhotra, J Mulenga, S Allen, E Hunter, J Tang, RA Kaslow, JK Sandberg |
PloS one | 2011 |
CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers
EM Songok, B Osero, L McKinnon, MK Rono, W Apidi, EJ Matey, AF Meyers, M Luo, J Kimani, C Wachihi, BT Ball, FA Plummer, S Mpoke |
Virology Journal | 2010 |
Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness
AC van der Kuyl, K Kozaczynska, KK Ariën, Y Gali, VR Balázs, SJ Dekker, F Zorgdrager, G Vanham, B Berkhout, M Cornelissen |
Retrovirology | 2010 |
Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1
H Ji, TB Ball, Z Ao, J Kimani, X Yao, FA Plummer |
Scandinavian Journal of Infectious Diseases | 2010 |
HIV viral set point and host immune control in individuals with HIV-specific CD8+ T-cell responses prior to HIV acquisition:
R Kaul, KS MacDonald, NJ Nagelkerke, J Kimani, K Fowke, TB Ball, M Luo, A Kariri, W Jaoko, S Moses, S Rowland-Jones, FA Plummer |
AIDS | 2010 |
Resilience and mental health
DM Davydov, R Stewart, K Ritchie, I Chaudieu |
Clinical Psychology Review | 2010 |
Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients of Mumbai, India: Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients
U Shankarkumar, A Pawar, K Ghosh, S Bajpai, A Pazare |
International Journal of Immunogenetics | 2010 |
Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses
D Sirskyj, F Diaz-Mitoma, A Golshani, A Kumar, A Azizi |
Immunology and Cell Biology | 2010 |
The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors
RA Koup, BS Graham, DC Douek |
Nature Reviews Immunology | 2010 |
Preinfection Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T Lymphocytes Failed To Prevent HIV Type 1 Infection from Strains Genetically Unrelated to Viruses in Long-Term Exposed Partners
Y Liu, A Woodward, H Zhu, T Andrus, J McNevin, J Lee, JI Mullins, L Corey, MJ McElrath, T Zhu |
Journal of virology | 2009 |
Persistent Immune Responses Induced by a Human Immunodeficiency Virus DNA Vaccine Delivered in Association with Electroporation in the Skin of Nonhuman Primates
F Martinon, K Kaldma, R Sikut, S Čulina, G Romain, M Tuomela, M Adojaan, A Männik, U Toots, T Kivisild, J Morin, P Brochard, B Delache, A Tripiciano, F Ensoli, I Stanescu, RL Grand, M Ustav |
Human Gene Therapy | 2009 |
The search for protection against HIV infection
R Detels |
Annals of Epidemiology | 2009 |
Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization
MD Co, ED Kilpatrick, AL Rothman |
Immunology | 2009 |
Repeated Rectal SHIVSF162P3Exposures Do Not Consistently Induce Sustained T Cell Responses Prior to Systemic Infection in the Repeat-Low Dose Preclinical Macaque Model
EN Kersh, W Luo, DR Adams, P Srinivasan, JM Smith, N Promadej-Lanier, D Ellenberger, JG Garcia-Lerma, S Butera, R Otten |
AIDS Research and Human Retroviruses | 2009 |
Case 11-2009 : A 47-Year-Old Man with Fever, Headache, Rash, and Vomiting
RC Cabot, NL Harris, JA Shepard, ES Rosenberg, AM Cort, SH Ebeling, CC Peters, SK Bell, ES Rosenberg |
New England Journal of Medicine | 2009 |
Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV—Study in domestic pigs
T Mölder, M Adojaan, K Kaldma, M Ustav, R Sikut |
Vaccine | 2009 |
HIV Protocols
VR Prasad, GV Kalpana |
HIV Protocols | 2009 |
HIV Protocols
VR Prasad, GV Kalpana |
HIV Protocols | 2009 |
HIV Protocols
VR Prasad, GV Kalpana |
HIV Protocols | 2009 |
HIV Protocols
VR Prasad, GV Kalpana |
HIV Protocols | 2009 |
Broadly cross-reactive CD4+ and CD8+ T-cell responses to avian influenza A (H5N1) in healthy individuals in the UK and Viet Nam
Laurel Yong-Hwa Lee1, Lien Anh Ha2, Cameron Simmons2, Menno D. de Jong2, Nguyen Van Vinh Chau2, Reto Schumacher1, Yan Chun Peng1, Andrew J. McMichael1*, Jeremy J. Farrar2, Geoffrey L. Smith3, Alain R. M. Townsend4, Brigitte A. Askonas1, Sarah Rowland-Jones1, and Tao Dong1* |
Journal of Clinical Investigation | 2008 |
The Spread, Treatment, and Prevention of HIV-1: Evolution of a Global Pandemic
Myron S. Cohen, Nick Hellmann, Jay Levy, Kevin DeCock, and Joep Lange |
Journal of Clinical Investigation | 2008 |
Immunogenically optimized peptides derived from natural mutants of HIV CTL epitopes and peptide combinatorial libraries
SE Blondelle, R Moya-Castro, K Osawa, K Schroder, DB Wilson |
Biopolymers | 2008 |
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV
E Mizukoshi, C Eisenbach, BR Edlin, KP Newton, S Raghuraman, C Weiler-Normann, LH Tobler, MP Busch, M Carrington, JA McKeating, TR O'Brien, B Rehermann |
The Journal of Infectious Diseases | 2008 |
Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals
EC Speelmon, D Livingston-Rosanoff, AL Desbien, J Lee, WD Wick, F Hladik, MJ McElrath |
AIDS Research and Human Retroviruses | 2008 |
Not just sheer luck! Immune correlates of protection against HIV-1 infection
L Piacentini, C Fenizia, V Naddeo, M Clerici |
Vaccine | 2008 |
Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus
F Martinon, P Brochard, M Ripaux, B Delache, G Aurégan, B Vaslin, RL Grand |
Vaccine | 2008 |
Modeling HIV Immune Response and Validation with Clinical Data
HT Banks, M Davidian, S Hu, GM Kepler, ES Rosenberg |
Journal of Biological Dynamics | 2008 |
An Asymmetric Model of Heterozygote Advantage at Major Histocompatibility Complex Genes: Degenerate Pathogen Recognition and Intersection Advantage
RJ Stoffels, HG Spencer |
Genetics | 2008 |
Deficiency of HIV-Gag-Specific T Cells in Early Childhood Correlates with Poor Viral Containment
SH Huang, J Dunkley-Thompson, YH Tang, EA Macklin, J Steel-Duncan, I Singh-Minott, EG Ryland, M Smikle, BD Walker, CD Christie, ME Feeney |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity
A Joseph, JH Zheng, A Follenzi, T DiLorenzo, K Sango, J Hyman, K Chen, A Piechocka-Trocha, C Brander, E Hooijberg, DA Vignali, BD Walker, H Goldstein |
Journal of virology | 2008 |
Induction of Broad Cross-Subtype-Specific HIV-1 Immune Responses by a Novel Multivalent HIV-1 Peptide Vaccine in Cynomolgus Macaques
A Azizi, DE Anderson, JV Torres, A Ogrel, M Ghorbani, C Soare, P Sandstrom, J Fournier, F Diaz-Mitoma |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.
van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, Abdool Karim Q, Grobler A, Barnabas N, Iriogbe I, Abdool Karim SS |
PloS one | 2008 |
Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India
S Pallikkuth, A Wanchu, A Bhatnagar, RK Sachdeva, M Sharma |
Clinical and vaccine immunology : CVI | 2007 |
The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy
XX Gu, FY Yue, CM Kovacs, MA Ostrowski |
PloS one | 2007 |
The potential of topical DNA vaccines adjuvanted by cytokines
J Lisziewicz, SA Calarota, F Lori |
Expert Opinion on Biological Therapy | 2007 |
Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women
T Hirbod, K Broliden |
Journal of Internal Medicine | 2007 |
Viral peptide immunogens: current challenges and opportunities
A Azizi, F Diaz-Mitoma |
Journal of Peptide Science | 2007 |
Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3
M Saini, E Hadas, DJ Volsky, MJ Potash |
Vaccine | 2007 |
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses
X Huang, L Liu, L Ren, C Qiu, Y Wan, J Xu |
Vaccine | 2007 |
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
S Létourneau, EJ Im, T Mashishi, C Brereton, A Bridgeman, H Yang, L Dorrell, T Dong, B Korber, AJ McMichael, T Hanke |
PloS one | 2007 |
HIV/AIDS Vaccine
JY Choi |
Journal of Korean Medical Association | 2007 |
Researching protective and promotive factors in mental health
V Patel, A Goodman |
International Journal of Epidemiology | 2007 |
HIV-1 Subtype C Gag-Specific T-Cell Responses in Relation to Human Leukocyte Antigens in a Diverse Population of HIV-Infected Ethiopians:
A Tsegaye, L Ran, D Wolday, B Petros, W Dorigo, E Piriou, T Messele, E Sanders, T Tilahun, D Eshetu, H Schuitemaker, RA Coutinho, F Miedema, J Borghans, D Baarle |
Journal of acquired immune deficiency syndromes (1999) | 2007 |
Mapping the future of HIV vaccines
GJ Nabel |
Nature Reviews Microbiology | 2007 |
The Role of Cytokines which Signal through the Common γ Chain Cytokine Receptor in the Reversal of HIV Specific CD4+ and CD8+ T Cell Anergy
XX Gu, FY Yue, CM Kovacs, MA Ostrowski, D Nixon |
PloS one | 2007 |
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
S Létourneau, EJ Im, T Mashishi, C Brereton, A Bridgeman, H Yang, L Dorrell, T Dong, B Korber, AJ McMichael, T Hanke, D Nixon |
PloS one | 2007 |
Availability of a Diversely Avid CD8 + T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p24 19–27 Epitope
KL Schaubert, DA Price, N Frahm, J Li, HL Ng, A Joseph, E Paul, B Majumder, V Ayyavoo, E Gostick, S Adams, FM Marincola, AK Sewell, M Altfeld, JM Brenchley, DC Douek, OO Yang, C Brander, H Goldstein, J Kan-Mitchell |
Journal of immunology (Baltimore, Md. : 1950) | 2007 |
Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals
BL Shacklett |
Current HIV/AIDS Reports | 2006 |
Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans
E Bégaud, L Chartier, V Marechal, J Ipero, J Léal, P Versmisse, G Breton, A Fontanet, C Capoulade-Metay, H Fleury, F Barré-Sinoussi, D Scott-Algara, G Pancino |
Retrovirology | 2006 |
Resistance to HIV infection
M Marmor, K Hertzmark, SM Thomas, PN Halkitis, M Vogler |
Journal of urban health : bulletin of the New York Academy of Medicine | 2006 |
Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma
M Lambert, M Gannagé, A Karras, M Abel, C Legendre, D Kerob, F Agbalika, PM Girard, C Lebbe, S Caillat-Zucman |
Blood | 2006 |
Protective immunity against hepatitis C virus infection
LN Elliott, AR Lloyd, JB Ziegler, RA Ffrench |
Immunology and Cell Biology | 2006 |
Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals
BL Shacklett |
Current Infectious Disease Reports | 2006 |
HIV VACCINES
AJ McMichael |
Annual Review of Immunology | 2006 |
Amplified transmission of HIV-1: missing link in the HIV pandemic
MS Cohen |
Transactions of the American Clinical and Climatological Association | 2006 |
Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection
J Yu, H Chen, H Horton, A Bansal, JM McElrath, R Reichman, P Goepfert, X Jin |
Journal of Medical Virology | 2006 |
Upregulation of Interferon-?? and RANTES in the Cervix of HIV-1-Seronegative Women With High-Risk Behavior
T Hirbod, J Nilsson, S Andersson, C Uberti-Foppa, D Ferrari, M Manghi, J Andersson, L Lopalco, K Broliden |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2006 |
Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination
XT Song, M Aldrich, SY Chen |
Expert Review of Vaccines | 2006 |
Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities
K Luzuriaga, ML Newell, F Dabis, JL Excler, JL Sullivan |
The Lancet | 2006 |
Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Z Moodie, Y Huang, L Gu, J Hural, SG Self |
Journal of Immunological Methods | 2006 |
Interactive association of proviral load and IFN-γ-secreting T cell responses in HIV-1C infection
VA Novitsky, PB Gilbert, K Shea, MF McLane, N Rybak, I Klein, I Thior, T Ndung'u, TH Lee, ME Essex |
Virology | 2006 |
Progress towards an HIV vaccine based on recombinant Bacillus Calmette–Guérin: failures and challenges
J Joseph, N Saubi, E Pezzat, JM Gatell |
Expert Review of Vaccines | 2006 |
Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes:
J Xu, L Ren, X Huang, C Qiu, Y Liu, Y Liu, Y Shao |
AIDS | 2006 |
Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response
JD Boyer, S Kumar, T Robinson, R Parkinson, L Wu, M Lewis, DI Watkins, DB Weiner |
Journal of Medical Primatology | 2006 |
Cross-Clade Conservation of HIV Type 1 Nef Immunodominant Regions Recognized by CD8+T Cells of HIV Type 1 CRF02_AG-Infected Ivorian (West Africa)
A Inwoley, P Recordon-Pinson, M Dupuis, J Gaston, M Genête, A Minga, F Letourneur, F Rouet, J Choppin, H Fleury, JG Guillet, M Andrieu |
AIDS Research and Human Retroviruses | 2005 |
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
SH Kaufmann, AJ McMichael |
Nature Medicine | 2005 |
Major Histocompatibility Complex Class II (HLA-DRB and -DQB) Allele Frequencies in Botswana: Association with Human Immunodeficiency Virus Type 1 Infection
T Ndung'u, S Gaseitsiwe, E Sepako, F Doualla-Bell, T Peter, S Kim, I Thior, VA Novitsky, M Essex |
Clinical and vaccine immunology : CVI | 2005 |
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants☆
JA Slyker, BL Lohman, DA Mbori-Ngacha, M Reilly, EG Wee, T Dong, AJ McMichael, SL Rowland-Jones, T Hanke, G John-Stewart |
Vaccine | 2005 |
Global human genetics of HIV-1 infection and China
TF ZHU, TJ FENG, X XIAO, H WANG, BP ZHOU |
Cell Research | 2005 |
Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera
SA Tenenbaum, CA Morris, SS Alexander, HE McFerrin, RF Garry, CA Leissinger |
Virology Journal | 2005 |
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes
F Bernardin, D Kong, L Peddada, LA Baxter-Lowe, E Delwart |
Journal of virology | 2005 |
Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post-Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials
BE Shepherd, PB Gilbert, Y Jemiai, A Rotnitzky |
Biometrics | 2005 |
The challenges of HIV vaccine development and testing
WA Burgers, C Williamson |
Best Practice & Research Clinical Obstetrics & Gynaecology | 2005 |
Mucosal Immunology
WR Brown |
Mucosal Immunology | 2005 |
Clustered epitopes within the Gag–Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens
E Bolesta, J Gzyl, A Wierzbicki, D Kmieciak, A Kowalczyk, Y Kaneko, A Srinivasan, D Kozbor |
Virology | 2005 |
Might male circumcision be more protective against HIV in the highly exposed? An immunological hypothesis:
MJ Wawer, SJ Reynolds, D Serwadda, G Kigozi, N Kiwanuka, RH Gray |
AIDS | 2005 |
Contrasting B cell- and T cell-based protective vaccines
VA Jansen, HK Altes, GA Funk, D Wodarz |
Journal of Theoretical Biology | 2005 |
Les mécanismes de résistance à la transmission sexuelle du VIH-1
A Eberhard, B Ponceau, F Biron, B Verrier |
Médecine et Maladies Infectieuses | 2005 |
Is there a role for plant-made vaccines in the prevention of HIV/AIDS?
DE Webster, MC Thomas, R Pickering, A Whyte, IB Dry, PR Gorry, SL Wesselingh |
Immunology and Cell Biology | 2005 |
The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients
MH Nikolova, MN Muhtarova, HB Taskov, K Kostov, L Vezenkov, A Mihova, L Boumsell, A Bensussan |
Cellular Immunology | 2005 |
MHC, health, color, and reproductive success in sand lizards
M Olsson, T Madsen, E Wapstra, B Silverin, B Ujvari, H Wittzell |
Behavioral Ecology and Sociobiology | 2005 |
Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences
TJ Scriba, J Megede, RH Glashoff, FK Treurnicht, SW Barnett, EJ van Rensburg |
Vaccine | 2005 |
Current Issues in the Development of a Vaccine to Prevent Human Immunodeficiency Virus: Insights from the Society of Infectious Diseases Pharmacists
EG Sahloff |
Pharmacotherapy | 2005 |
Significance of the detection of HIV-1 gag- and/or pol-CD8/A2 T-lymphocytes in HIV-patients
R Wu, GC Owen, T Liu, GQ Shen, RI Morris |
Immunology Letters | 2005 |
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques
J Su, MA Luscher, Y Xiong, T Rustam, RR Amara, E Rakasz, HL Robinson, KS MacDonald |
International Immunology | 2005 |
A la recherche du vaccin contre le SIDA
MP Girard |
Bulletin de l'Académie nationale de médecine | 2005 |
Combined Effect of CCR5-Δ32 Heterozygosity and the CCR5 Promoter Polymorphism −2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission
F Hladik, H Liu, E Speelmon, D Livingston-Rosanoff, S Wilson, P Sakchalathorn, Y Hwangbo, B Greene, T Zhu, MJ McElrath |
Journal of virology | 2005 |
CD8 + T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligodeoxynucleotides
JQ Jiang, A Patrick, RB Moss, KL Rosenthal |
Journal of virology | 2005 |
Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity
A Sette, J Sidney, HH Bui, MF del Guercio, J Alexander, J Loffredo, DI Watkins, BR Mothé |
Immunogenetics | 2005 |
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy
G Borkow, Z Bentwich |
Clinical microbiology reviews | 2004 |
Novel and Promiscuous CTL Epitopes in Conserved Regions of Gag Targeted by Individuals with Early Subtype C HIV Type 1 Infection from Southern Africa
AM Masemola, TN Mashishi, G Khoury, H Bredell, M Paximadis, T Mathebula, D Barkhan, A Puren, E Vardas, M Colvin, L Zijenah, D Katzenstein, R Musonda, S Allen, N Kumwenda, T Taha, G Gray, J McIntyre, SA Karim, HW Sheppard, CM Gray |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Insights Into the Role of Host Genetic and T-Cell Factors in Resistance to HIV Transmission From Studies of Highly HIV-Exposed Thais
JM McNicholl, N Promadej |
Immunologic Research | 2004 |
Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals
Q Lizeng, C Nilsson, S Sourial, S Andersson, O Larsen, P Aaby, M Ehnlund, E Björling |
Journal of virology | 2004 |
DNA vaccines against human immunodeficiency virus type 1
MJ Estcourt, AJ McMichael, T Hanke |
Immunological Reviews | 2004 |
Impact of host genetics on HIV disease progression and treatment
D Nolan, S Gaudieri, M John, S Mallal |
AIDS | 2004 |
Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens
Y Paterson, R Johnson |
Expert Review of Vaccines | 2004 |
HIV Type 1 Antigen-Responsive CD4+T-Lymphocytes in Exposed Yet HIV Type 1 Seronegative Ugandans
A Kebba, P Kaleebu, J Serwanga, S Rowland, D Yirrell, R Downing, J Gilmour, N Imami, F Gotch, J Whitworth |
AIDS Research and Human Retroviruses | 2004 |
Human Leukocyte Antigen (HLA) B*18 and Protection against Mother-to-Child HIV Type 1 Transmission
C Farquhar, S Rowland-Jones, D Mbori-Ngacha, M Redman, B Lohman, J Slyker, P Otieno, E Obimbo, T Rostron, J Ochieng, J Oyugi, R Bosire, G John-Stewart |
AIDS Research and Human Retroviruses | 2004 |
Cross-Clade CD8 T-Cell Responses to HIVIIIB and Chinese B??? and C/B??? Viruses in North American and Chinese HIV-Seropositive Donors:
V Fran??ois-Bongarcon, Y Feng, SK Lee, G Chen, P Shankar, Y Liu, X Tao, Y Shao, J Lieberman |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2004 |
Approaches for the design and evaluation of HIV-1 DNA vaccines
SA Calarota, DB Weiner |
Expert Review of Vaccines | 2004 |
Therapeutic vaccination against HIV
B Wahren, M Liu |
Expert Review of Vaccines | 2004 |
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
G Pantaleo, RA Koup |
Nature Medicine | 2004 |
HIV Type 1-Specific Inter- and Intrasubtype Cellular Immune Responses in HIV Type 1-Infected Ugandans
A Rutebemberwa, B Auma, J Gilmour, G Jones, D Yirrell, S Rowland, N Imami, C Watera, P Kaleebu, J Whitworth, F Gotch |
AIDS Research and Human Retroviruses | 2004 |
Th1/Th2 cells in inflammatory disease states: therapeutic implications
RB Moss, T Moll, M El-Kalay, C Kohne, WS Hoo, J Encinas, DJ Carlo |
Expert Opinion on Biological Therapy | 2004 |
Full-Length gag Sequences of HIV Type 1 Subtype C Recent Seroconverters from Pune, India
S Kurle, S Tripathy, S Jadhav, K Agnihotri, R Paranjape |
AIDS Research and Human Retroviruses | 2004 |
HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis
Rupert Kaul, John Rutherford, Sarah L Rowland-Jones, Joshua Kimani, James Isaiah Onyango, Keith Fowke, Kelly MacDonald, Job J Bwayo, Andrew J McMichael, Francis A Plummer |
AIDS | 2004 |
Risk Associated HIV-1 Cross-Clade Resistance of Whole Peripheral Blood Mononuclear Cells From Exposed Uninfected Individuals With Wild-Type CCR5:
R John, S Arango-Jaramillo, GJ Finny, DH Schwartz |
Journal of acquired immune deficiency syndromes (1999) | 2004 |
Structures of HLA-A*1101 Complexed with Immunodominant Nonamer and Decamer HIV-1 Epitopes Clearly Reveal the Presence of a Middle, Secondary Anchor Residue
L Li, M Bouvier |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1
K Ritola, CD Pilcher, SA Fiscus, NG Hoffman, JA Nelson, KM Kitrinos, CB Hicks, JJ Eron, R Swanstrom |
Journal of virology | 2004 |
Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells
F Hladik, A Desbien, J Lang, L Wang, Y Ding, S Holte, A Wilson, Y Xu, M Moerbe, S Schmechel, MJ McElrath |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
HIV vaccines 1983–2003
AJ McMichael, T Hanke |
Nature Medicine | 2003 |
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines
WP Kong, Y Huang, ZY Yang, BK Chakrabarti, Z Moodie, GJ Nabel |
Journal of virology | 2003 |
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression
C Farquhar, G John-Stewart |
Clinical & Experimental Immunology | 2003 |
A review of vaccines for HIV prevention
M Mwau, AJ McMichael |
The Journal of Gene Medicine | 2003 |
Demystified. Human endogenous retroviruses
PN Nelson, PR Carnegie, J Martin, HD Ejtehadi, P Hooley, D Roden, S Rowland-Jones, P Warren, J Astley, PG Murray |
Molecular pathology : MP | 2003 |
Repetitive and consistent cervicovaginal exposure to certain viral pathogens appears to protect against their sexual acquisition in some women: potential mechanisms
J Laurence |
Journal of Reproductive Immunology | 2003 |
Vaccine for AIDS and Ebola virus infection
GJ Nabel |
Virus Research | 2003 |
Interleukin 12-Augmented T Cell Proliferation of Peripheral Blood Mononuclear Cells from HIV-Seropositive Individuals Is Associated with Interleukin 12 Receptor β2 Upregulation
ML Jones, JM Young, QR Huang, RL Puls, CA Webber, EM Benson |
AIDS Research and Human Retroviruses | 2003 |
Cross-Reactive CD8+ T Cell Epitopes Identified in US Adolescent Minorities
S Sabbaj, A Bansal, GD Ritter, C Perkins, BH Edwards, E Gough, J Tang, JJ Szinger, B Korber, CM Wilson, RA Kaslow, MJ Mulligan, PA Goepfert |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2003 |
AIDS and Other Manifestations of HIV Infection
D Ashkin, Y Hale, E Hollender, M Lauzardo, M Narita, AE Pitchenik, M Salfinger, JJ Stambaugh |
AIDS and Other Manifestations of HIV Infection | 2003 |
Design and construction of T-lymphocyte epitope-based therapeutic HIV-1 vaccines
MJ Newman, D McKinney, R Chesnut, A Sette, C Wilson, B Livingston |
Clinical and Applied Immunology Reviews | 2003 |
Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development
C Williamson, L Morris, MF Maughan, LH Ping, SA Dryga, R Thomas, EA Reap, T Cilliers, J Harmelen, A Pascual, G Ramjee, G Gray, R Johnston, SA Karim, R Swanstrom |
AIDS Research and Human Retroviruses | 2003 |
Suppression of HIV-1 Replication by HIV-1-Irrelevant CD8 + Cytotoxic T Lymphocytes Resulting in Preservation of Persistently HIV-1-Infected Cells In Vitro
H Liu, T Ohashi, T Masuda, X Zhou, M Kubo, M Kannagi |
Viral Immunology | 2003 |
The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients
D Vázquez-Blomquist, E Iglesias, EE González-Horta, CA Duarte |
Vaccine | 2003 |
Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects:
J Eyeson, D King, MJ Boaz, E Sefia, S Tomkins, A Waters, PJ Easterbrook, A Vyakarnam |
AIDS | 2003 |
Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines
J zur Megede, GR Otten, B Doe, H Liu, L Leung, JB Ulmer, JJ Donnelly, SW Barnett |
Journal of virology | 2003 |
Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome
JP McGettigan, K Naper, J Orenstein, M Koser, PM McKenna, MJ Schnell |
Journal of virology | 2003 |
Primary replication of a recombinant Sendai virus vector in macaques
K Terao, Y Suzaki, Y Ami, A Takeda, H Nakamura, A Kato, T Matano, M Kano, Y Nagai |
Journal of General Virology | 2002 |
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure
JH Skurnick, P Palumbo, A DeVico, BL Shacklett, FT Valentine, M Merges, R Kamin-Lewis, J Mestecky, T Denny, GK Lewis, J Lloyd, R Praschunus, A Baker, DF Nixon, S Stranford, R Gallo, SH Vermund, DB Louria |
The Journal of Infectious Diseases | 2002 |
Host Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries
G Borkow, Z Bentwich |
Clinical and vaccine immunology : CVI | 2002 |
Dendritic Cell Amplification of HIV Type 1-Specific CD8+T Cell Responses in Exposed, Seronegative Heterosexual Women
BL Shacklett, RE Means, M Larsson, DT Wilkens, TJ Beadle, MJ Merritt, N Bhardwaj, PE Palumbo, JH Skurnick, DB Louria, DF Nixon |
AIDS Research and Human Retroviruses | 2002 |
Design and tests of an HIV vaccine
A McMichael, M Mwau, T Hanke |
British Medical Bulletin | 2002 |
Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients
K Fukada, H Tomiyama, C Wasi, T Matsuda, S Kusagawa, H Sato, S Oka, Y Takebe, M Takiguchi |
AIDS | 2002 |
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
V Novitsky, UR Smith, P Gilbert, MF McLane, P Chigwedere, C Williamson, T Ndung'u, I Klein, SY Chang, T Peter, I Thior, BT Foley, S Gaolekwe, N Rybak, S Gaseitsiwe, F Vannberg, R Marlink, TH Lee, M Essex |
Journal of virology | 2002 |
The search for an HIV vaccine
MW Makgoba, N Solomon, TJ Tucker |
BMJ (Clinical research ed.) | 2002 |
HIV vaccine strategies
GJ Nabel |
Vaccine | 2002 |
HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity
G Makedonas, J Bruneau, H Lin, RP Sékaly, F Lamothe, NF Bernard |
AIDS | 2002 |
OPINION — VACCINES: The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
A McMichael, T Hanke |
Nature Reviews Immunology | 2002 |
Development of a novel allo-independent HIV-1 virus preparation for use in immunoassays
S Koesters, WJ Rutherford, KR Fowke |
Journal of Immunological Methods | 2002 |
HIV-1 Therapeutic Vaccines
SK Loes, B Autran |
Journal of Infection | 2002 |
Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E
MD Co, M Terajima, J Cruz, FA Ennis, AL Rothman |
Virology | 2002 |
Molecular virology and immunology of HIV infection
J Chinen, WT Shearer |
Journal of Allergy and Clinical Immunology | 2002 |
What information is needed to design effective vaccination against intracellular pathogens causing chronic disease?
PA Bretscher, D Hamilton, O Ogunremi |
Expert Review of Vaccines | 2002 |
AIDS Vaccine Research
V Lukashov, J Goudsmit, W Paxton |
AIDS Vaccine Research | 2002 |
AIDS Vaccine Research: Challenges and Opportunities
G Nabel |
AIDS Vaccine Research | 2002 |
Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats
MJ Burkhard, L Valenski, S Leavell, GA Dean, WA Tompkins |
Vaccine | 2002 |
Effects of MHC Class I on HIV/SIV Disease in Primates:
M Carrington, RE Bontrop |
AIDS, Supplement | 2002 |
Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects:
C Devito, J Hinkula, R Kaul, J Kimani, P Kiama, L Lopalco, C Barass, S Piconi, D Trabattoni, JJ Bwayo, F Plummer, M Clerici, K Broliden |
Journal of acquired immune deficiency syndromes (1999) | 2002 |
CD8+ T-cell immunity to HIV infection
P Piazza, Z Fan, CR Rinaldo |
Clinics in Laboratory Medicine | 2002 |
HIV: Bad news for stop–start therapy?
AJ McMichael, SL Rowland-Jones |
Nature | 2002 |
Boosting of SIV-Specific T Cell Responses in Rhesus Macaques That Resist Repeated Intravaginal Challenge with SIVmac251
BL Shacklett, B Ling, RS Veazey, A Luckay, WJ Moretto, DT Wilkens, J Hu, ZR Israel, DF Nixon, PA Marx |
AIDS Research and Human Retroviruses | 2002 |
Current strategies in the treatment of HIV infection
OJ Cohen, AS Fauci |
Disease-a-Month | 2002 |
Induction of a Strong HIV-Specific CD8 + T Cell Response in Mice Using a Fowlpox Virus Vector Expressing an HIV-1 Multi-CTL-Epitope Polypeptide
DV Blomquist, P Green, SM Laidlaw, MA Skinner, P Borrow, CA Duarte |
Viral Immunology | 2002 |
Coreceptor Utilization of HIV Type 1 Subtype E Viral Isolates from Thai Men with HIV Type 1-Infected and Uninfected Wives
U Utaipat, A Duerr, DL Rudolph, C Yang, ST Butera, D Lupo, T Pisell, A Tangmunkongvorakul, N Kamtorn, N Nantachit, T Nagachinta, V Suriyanon, V Robison, KE Nelson, N Sittisombut, RB Lal |
AIDS Research and Human Retroviruses | 2002 |
HIV-1 vaccines: the search continues
JP McGettigan, PM McKenna, MJ Schnell |
Clinics in Laboratory Medicine | 2002 |
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance
H Loemba, B Brenner, MA Parniak, S Ma'ayan, B Spira, D Moisi, M Oliveira, M Detorio, M Essex, MA Wainberg |
Antiviral Research | 2002 |
Human Immunodeficiency Virus (HIV)–Specific Cellular Immune Responses in Newborns Exposed to HIV In Utero
L Kuhn, S Meddows‐Taylor, G Gray, C Tiemessen |
Clinical Infectious Diseases | 2002 |
HIV T cell vaccines, the importance of clades
A McMichael, M Mwau, T Hanke |
Vaccine | 2002 |
The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes
T Mashishi, CM Gray |
Clinical chemistry and laboratory medicine : CCLM / FESCC | 2002 |
Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy
MM Thomson, L Pérez-Álvarez, R Nájera |
The Lancet Infectious Diseases | 2002 |
Epidermal Powder Immunization with a Recombinant HIV gp120 Targets Langerhans Cells and Induces Enhanced Immune Responses
D Chen, C Zuleger, Q Chu, YF Maa, J Osorio, LG Payne |
AIDS Research and Human Retroviruses | 2002 |
Le long chemin du vaccin contre le sida
M Girard |
Annales de l'Institut Pasteur/Actualités | 2002 |
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades
Thomas G Bird, Rupert Kaul, Timothy Rostron, Joshua Kimani, Joanne Embree, Paul P Dunn, Job J Bwayo, Francis A Plummer, Sarah L Rowland-Jones, Tao Dong, |
AIDS | 2002 |
HIV-1 Polymorphism: a Challenge for Vaccine Development - A Review
MG Morgado, ML Guimarães, B Galvão-Castro |
Memórias do Instituto Oswaldo Cruz | 2002 |
Lymphocyte Activation and Immune Regulation IX
S Gupta, E Butcher, W Paul |
Lymphocyte Activation and Immune Regulation IX | 2002 |
Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C
V Novitsky, H Cao, N Rybak, P Gilbert, MF McLane, S Gaolekwe, T Peter, I Thior, T Ndung'u, R Marlink, TH Lee, M Essex |
Journal of virology | 2002 |
Rhesus Macaque Resistance to Mucosal Simian Immunodeficiency Virus Infection Is Associated with a Postentry Block in Viral Replication
B Peng, R Voltan, L Lim, Y Edghill-Smith, S Phogat, DS Dimitrov, K Arora, M Leno, S Than, R Woodward, PD Markham, M Cranage, M Robert-Guroff |
Journal of virology | 2002 |
Computer-Based Design of an HLA-Haplotype and HIV-Clade Independent Cytotoxic T-Lymphocyte (CTL) Assay for Monitoring HIV-Specific Immunity
M Amicosante, C Gioia, C Montesano, R Casetti, S Topino, G DOffizi, G Cappelli, G Ippolito, V Colizzi, F Poccia, LP Pucillo |
Molecular Medicine | 2002 |
AIDS in Africa
M Essex, S Mboup, PJ Kanki, RG Marlink, SD Tlou, M Holme |
2002 | |
Human Immunodeficiency Virus-Specific CD8 + T Cells in Human Breast Milk
S Sabbaj, BH Edwards, MK Ghosh, K Semrau, S Cheelo, DM Thea, L Kuhn, GD Ritter, MJ Mulligan, PA Goepfert, GM Aldrovandi |
Journal of virology | 2002 |
Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal |
Science | 2002 |
Characterization of the Peptide-Binding Specificity of Mamu-B*17 and Identification of Mamu-B*17-Restricted Epitopes Derived from Simian Immunodeficiency Virus Proteins
BR Mothé, J Sidney, JL Dzuris, ME Liebl, S Fuenger, DI Watkins, A Sette |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
The Magnitude and Specificity of Influenza A Virus-Specific Cytotoxic T-Lymphocyte Responses in Humans Is Related to HLA-A and -B Phenotype
AC Boon, G de Mutsert, YM Graus, RA Fouchier, K Sintnicolaas, AD Osterhaus, GF Rimmelzwaan |
Journal of virology | 2002 |
Detailed Analysis of CD4 + Th Responses to Envelope and Gag Proteins of Simian Immunodeficiency Virus Reveals an Exclusion of Broadly Reactive Th Epitopes from the Glycosylated Regions of Envelope
S Sarkar, V Kalia, M Murphey-Corb, RC Montelaro |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
Sustained Peptide-Specific Gamma Interferon T-Cell Response in Rhesus Macaques Immunized with Human Immunodeficiency Virus gag DNA Vaccines
MJ Caulfield, S Wang, JG Smith, TW Tobery, X Liu, ME Davies, DR Casimiro, TM Fu, A Simon, RK Evans, EA Emini, J Shiver |
Journal of virology | 2002 |
Diversity Considerations in HIV-1 Vaccine Selection
B Gaschen, J Taylor, K Yusim, B Foley, F Gao, D Lang, V Novitsky, B Haynes, BH Hahn, T Bhattacharya, B Korber |
Science | 2002 |
Magnitude of Functional CD8 + T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma
BH Edwards, A Bansal, S Sabbaj, J Bakari, MJ Mulligan, PA Goepfert |
Journal of virology | 2002 |
Differences Between T Cell Epitopes Recognized After Immunization and After Infection
TU Vogel, H Horton, DH Fuller, DK Carter, K Vielhuber, DH OConnor, T Shipley, J Fuller, G Sutter, V Erfle, N Wilson, LJ Picker, DI Watkins |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
HIV vaccines: Biological and clinical considerations
MP DSouza, MA Allen, MI Johnston |
Current Infectious Disease Reports | 2002 |
Neutralizing Antibodies Mechanism of Neutralization and Protective Activity Against HIV-1
Y Xiao, X Dong, YH Chen |
Immunologic Research | 2002 |
Late seroconversion in HIV-1 "resistant" prostitutes despite pre-existing HIV-1 specific CD8+ responses: association with reduced HIV exposure
Rupert Kaul, Sarah L. Rowland-Jones, Joshua Kimani, Tao Dong, Hong-Bing Yang, Peter Kiama, Timothy Rostron, Ephantus Njagi, Job J. Bwayo, Kelly S. MacDonald, Andrew J. McMichael, Francis A. Plummer |
Journal of Clinical Investigation | 2001 |
HIV specific CD8+ lymphocyte responses correlate with resistance to HIV infection, and target different epitopes in seronegative and infected subjects
Rupert Kaul, Tao Dong, Francis A. Plummer, Joshua Kimani, Timothy Rostron, Peter Kiama, Ephantus Njagi, Erastus Irungu, Bashir Farah, Julius Oyugi, Rana Chakraborty, Kelly S. MacDonald, Job J. Bwayo, Andrew McMichael, Sarah L. Rowland-Jones |
Journal of Clinical Investigation | 2001 |
The realistic hope for curbing the expanding HIV pandemic
Norman Letvin, Bruce D. Walker |
Journal of Clinical Investigation | 2001 |
Cellular immune responses to HIV
AJ McMichael, SL Rowland-Jones |
Nature | 2001 |
The influence of HLA genotype on AIDS
M Carrington, SJ O'Brien |
Annual Review of Medicine | 2001 |
Current Protocols in Immunology
EH Leiter |
Current Protocols in Immunology | 2001 |
Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics?
RP Bucy, JM Kilby |
AIDS | 2001 |
Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection
AM Grabowska, F Lechner, P Klenerman, PJ Tighe, S Ryder, JK Ball, BJ Thomson, WL Irving, RA Robins |
European Journal of Immunology | 2001 |
Human Immunodeficieny Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection
DE Cohen, BD Walker |
Clinical Infectious Diseases | 2001 |
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV
DK Wong, DD Dudley, PB Dohrenwend, GM Lauer, RT Chung, DL Thomas, BD Walker |
Journal of virology | 2001 |
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design
V Novitsky, N Rybak, MF McLane, P Gilbert, P Chigwedere, I Klein, S Gaolekwe, SY Chang, T Peter, I Thior, T Ndung'u, F Vannberg, BT Foley, R Marlink, TH Lee, M Essex |
Journal of virology | 2001 |
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates
JP McGettigan, HD Foley, IM Belyakov, JA Berzofsky, RJ Pomerantz, MJ Schnell |
Journal of virology | 2001 |
Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted
Y Guan, JB Whitney, M Detorio, MA Wainberg |
Journal of virology | 2001 |
Failure to detect HLA-A*6802-restricted CD8+ T cells specific for Chlamydia trachomatis antigens in subjects from trachoma-endemic communities
OS Mahdi, HC Whittle, H Joof, DC Mabey, RL Bailey |
Clinical & Experimental Immunology | 2001 |
Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals
J Engelmayer, M Larsson, A Lee, M Lee, WI Cox, RM Steinman, N Bhardwaj |
Journal of virology | 2001 |
HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang Rai, Northern Thailand
B Sriwanthana, T Hodge, TD Mastro, CS Dezzutti, K Bond, HA Stephens, LG Kostrikis, K Limpakarnjanarat, NL Young, SH Qari, RB Lal, D Chandanayingyong, JM McNicholl |
AIDS Research and Human Retroviruses | 2001 |
High Levels of CD8-Positive Lymphocytes Expressing CD45R0, Granzyme B, and Ki-67 in Lymph Nodes of HIV-Infected Individuals Are Not Associated with Increased Mortality
C Espersen, B Pakkenberg, E Harder, G Pallesen, J Gerstoft, BK Pedersen, H Ullum |
AIDS Research and Human Retroviruses | 2001 |
Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design
KS MacDonald, L Matukas, JE Embree, K Fowke, J Kimani, NJ Nagelkerke, J Oyugi, P Kiama, R Kaul, MA Luscher, S Rowland-Jones, J Ndinya-Achola, E Ngugi, JJ Bwayo, FA Plummer |
Immunology Letters | 2001 |
Characterization of High-Risk HIV-1 Seronegative Hemophiliacs
JR Salkowitz, SF Purvis, H Meyerson, P Zimmerman, TR O'Brien, L Aledort, ME Eyster, M Hilgartner, C Kessler, BA Konkle, GC White, JJ Goedert, MM Lederman |
Clinical Immunology | 2001 |
A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay
TW Tobery, S Wang, XM Wang, MP Neeper, KU Jansen, WL McClements, MJ Caulfield |
Journal of Immunological Methods | 2001 |
Recent developments in human HIV-1 vaccine
D Dabelstein, B Cromer |
Family Practice | 2001 |
DNA Vaccination of Macaques with Several Different Nef Sequences Induces Multispecific T Cell Responses
I Couillin, F Letourneur, P Lefèbvre, JG Guillet, F Martinon |
Virology | 2001 |
Mucosal Exposure to Subinfectious Doses of SIV Primes Gut-Associated Antibody-Secreting Cells and T Cells: Lack of Enhancement by Nonneutralizing Antibody
N Polyanskaya, LA Bergmeier, SA Sharpe, N Cook, S Leech, G Hall, M Dennis, P Haaft, J Heeney, F Manca, T Lehner, MP Cranage |
Virology | 2001 |
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
K Broliden, J Hinkula, C Devito, P Kiama, J Kimani, D Trabbatoni, JJ Bwayo, M Clerici, F Plummer, R Kaul |
Immunology Letters | 2001 |
HIV in the Female Genital Tract: Viral Shedding and Mucosal Immunity:
L Al-Harthi, A Landay |
Clinical Obstetrics and Gynecology | 2001 |
Challenges and opportunities for development of an AIDS vaccine
GJ Nabel |
Nature | 2001 |
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
S L Rowland-Jones, S Pinheiro, R Kaul, P Hansasuta, G Gillespie, T Dong, F A Plummer, J B Bwayo, S Fidler, J Weber, A McMichael, V Appay |
Immunology Letters | 2001 |
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers
R Kaul, S L Rowland-Jones, J Kimani, K Fowke, T Dong, P Kiama, J Rutherford, E Njagi, F Mwangi, T Rostron, J Onyango, J Oyugi, K S MacDonald, J J Bwayo, F A Plummer |
Immunology Letters | 2001 |
Relative Dominance of Epitope-Specific Cytotoxic T-Lymphocyte Responses in Human Immunodeficiency Virus Type 1-Infected Persons with Shared HLA Alleles
CL Day, AK Shea, MA Altfeld, DP Olson, SP Buchbinder, FM Hecht, ES Rosenberg, BD Walker, SA Kalams |
Journal of virology | 2001 |
Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells
J Lisziewicz, DI Gabrilovich, G Varga, J Xu, PD Greenberg, SK Arya, M Bosch, JP Behr, F Lori |
Journal of virology | 2001 |
Route of Simian Immunodeficiency Virus Inoculation Determines the Complexity but Not the Identity of Viral Variant Populations That Infect Rhesus Macaques
JL Greenier, CJ Miller, D Lu, PJ Dailey, FX Lu, KJ Kunstman, SM Wolinsky, ML Marthas |
Journal of virology | 2001 |
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber, B Gaschen, K Yusim, R Thakallapally, C Kesmir, V Detours |
British Medical Bulletin | 2001 |
HIV-1 transmission and acute HIV-1 infection
P Hansasuta, SL Rowland-Jones |
British Medical Bulletin | 2001 |
Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines
RA Kaslow, C Rivers, J Tang, TJ Bender, PA Goepfert, RE Habib, K Weinhold, MJ Mulligan |
Journal of virology | 2001 |
CD8 + Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing
TM Allen, BR Mothé, J Sidney, P Jing, JL Dzuris, ME Liebl, TU Vogel, DH O'Connor, X Wang, MC Wussow, JA Thomson, JD Altman, DI Watkins, A Sette |
Journal of virology | 2001 |
Immunopathogenesis of HIV-1 infection
H Cao, BD Walker |
Clinics in Dermatology | 2000 |
HIV-1-specific cellular immune responses among HIV-1-resistant sex workers
KR Fowke, R Kaul, KL Rosenthal, J Oyugi, J Kimani, WJ Rutherford, NJ Nagelkerke, TB Ball, JJ Bwayo, JN Simonsen, GM Shearer, FA Plummer |
Immunology and Cell Biology | 2000 |
Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection
D Bienzle, KS Macdonald, KF Copeland, JJ Bwayo, FA Plummer, KL Rosenthal |
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses | 2000 |
Human memory CTL response specific for influenza A virus is broad and multispecific
C Gianfrani, C Oseroff, J Sidney, RW Chesnut, A Sette |
Human Immunology | 2000 |
Temporal Loss of Nef-Epitope CTL Recognition following Macaque Lipopeptide Immunization and SIV Challenge
L Mortara, F Letourneur, P Villefroy, C Beyer, H Gras-Masse, JG Guillet, I Bourgault-Villada |
Virology | 2000 |
Biomedical Research Reports
JY Lau, DN Standring |
Biomedical Research Reports | 2000 |
Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes and Protection Against Challenge in Rhesus Macaques Immunized with a Live Attenuated Simian Immunodeficiency Virus Vaccine
DF Nixon, SM Donahoe, WM Kakimoto, RV Samuel, KJ Metzner, A Gettie, T Hanke, PA Marx, RI Connor |
Virology | 2000 |
Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL
IM Belyakov, JD Ahlers, JD Clements, W Strober, JA Berzofsky |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Intranasal Immunization with HIV Reverse Transcriptase: Effect of Dose in the Induction of Helper T Cell Type 1 and 2 Immunity
SE Pacheco, RA Gibbs, A Ansari-Lari, P Rogers |
AIDS Research and Human Retroviruses | 2000 |
Live Attenuated HIV Vaccines: A Proposal for Further Research and Development
J Mills, R Desrosiers, E Rud, N Almond |
AIDS Research and Human Retroviruses | 2000 |
Identification of Highly Conserved and Broadly Cross-Reactive HIV Type 1 Cytotoxic T Lymphocyte Epitopes as Candidate Immunogens for Inclusion in Mycobacterium bovis BCG-Vectored HIV Vaccines
G Ferrari, DD Kostyu, J Cox, DV Dawson, J Flores, KJ Weinhold, S Osmanov |
AIDS Research and Human Retroviruses | 2000 |
Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer
N Meidenbauer, DT Harris, LE Spitler, TL Whiteside |
The Prostate | 2000 |
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia:
L Dorrell, AJ Hessell, M Wang, H Whittle, S Sabally, S Rowland-Jones, DR Burton, PW Parren |
AIDS | 2000 |
Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications
CS Cruz, R Tan, SL Rowland-Jones, BH Barber |
International Immunology | 2000 |
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
T Hanke, AJ McMichael |
Nature Medicine | 2000 |
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary CD4 + T Lymphocytes, Monocytes, and Dendritic Cells by Cytotoxic T Lymphocytes
ME Severino, NV Sipsas, PT Nguyen, SA Kalams, BD Walker, RP Johnson, OO Yang |
Journal of virology | 2000 |
Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide
MM Gherardi, JC Ramírez, M Esteban |
Journal of virology | 2000 |
HIV-1-Specific Mucosal CD8 + Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi
R Kaul, FA Plummer, J Kimani, T Dong, P Kiama, T Rostron, E Njagi, KS MacDonald, JJ Bwayo, AJ McMichael, SL Rowland-Jones |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
R Kaul, D Trabattoni, JJ Bwayo, D Arienti, A Zagliani, FM Mwangi, C Kariuki, EN Ngugi, KS MacDonald, TB Ball, M Clerici, FA Plummer |
AIDS | 1999 |
Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa
L Dorrell, T Dong, GS Ogg, S Lister, S McAdam, T Rostron, C Conlon, AJ McMichael, SL Rowland-Jones |
Journal of virology | 1999 |
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
T Hanke, RV Samuel, TJ Blanchard, VC Neumann, TM Allen, JE Boyson, SA Sharpe, N Cook, GL Smith, DI Watkins, MP Cranage, AJ McMichael |
Journal of virology | 1999 |
T lymphocyte responses in HIV-1 infection: implications for vaccine development
C Brander, BD Walker |
Current Opinion in Immunology | 1999 |
Use of Herpesvirus saimiri-immortalized macaque CD4+ T cell clones as stimulators and targets for assessment of CTL responses in macaque/AIDS models
A Kumar, HL Stipp, D Sheffer, O Narayan |
Journal of Immunological Methods | 1999 |
Frequency of CD8+ T Lymphocytes Specific for Lytic and Latent Antigens of Epstein–Barr Virus in Healthy Virus Carriers
G Benninger-Döring, S Pepperl, L Deml, S Modrow, H Wolf, W Jilg |
Virology | 1999 |
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
M Girard, A Habel, C Chanel |
Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie | 1999 |
Immune correlates of protection from HIV and AIDS – more answers but yet more questions
JL Heeney, P Beverley, A McMichael, G Shearer, J Strominger, B Wahren, J Weber, F Gotch |
Immunology Today | 1999 |
Is an HIV vaccine possible?
AJ McMichael, T Hanke |
Nature Medicine | 1999 |
HIV-Infekt
NH Brockmeyer, L Mertins |
1997 | |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |